Jeffrey W. Dunn - Oct 2, 2023 Form 4 Insider Report for SI-BONE, Inc. (SIBN)

Role
Director
Signature
/s/ Michael A. Pisetsky, Attorney-in-Fact for Jeffrey W. Dunn
Stock symbol
SIBN
Transactions as of
Oct 2, 2023
Transactions value $
-$337,338
Form type
4
Date filed
10/4/2023, 05:53 PM
Previous filing
Sep 6, 2023
Next filing
Nov 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SIBN Common Stock Options Exercise $86.4K +20K +28.72% $4.32 89.6K Oct 2, 2023 Direct
transaction SIBN Common Stock Sale -$424K -20K -22.31% $21.19 69.6K Oct 2, 2023 Direct F1, F2, F3
holding SIBN Common Stock 133K Oct 2, 2023 by Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SIBN Stock Option (Right to Buy) Options Exercise $0 -20K -19.75% $0.00 81.2K Oct 2, 2023 Common Stock 20K $4.32 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
F2 The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.96 to $21.51, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Includes 53,089 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents contingent right to receive one share of the Issuer's common stock.
F4 Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012.
F5 The shares subject to the option vest in equal monthly installments over four years commencing on the vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.